Invex Therapeutics Ltd

CHIA:IXC Stock Report

Market Cap: AU$5.0m

Invex Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.1yrs

Recent management updates

Recent updates

CEO

Invex Therapeutics has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Thomas Duthy
Executive Director4.1yrsAU$357.23k0.38%
A$ 19.1k
David McAuliffe
Non-Executive Chairman5.7yrsAU$57.24k4.46%
A$ 224.4k
David Wheeler
Non-Executive Directorless than a yearAU$36.17kno data

4.1yrs

Average Tenure

Experienced Board: IXC's board of directors are considered experienced (4.1 years average tenure).